These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 25592037)

  • 1. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
    Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
    Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion.
    Joseph JV; Conroy S; Tomar T; Eggens-Meijer E; Bhat K; Copray S; Walenkamp AM; Boddeke E; Balasubramanyian V; Wagemakers M; den Dunnen WF; Kruyt FA
    Cell Death Dis; 2014 Oct; 5(10):e1443. PubMed ID: 25275602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.
    Kahlert UD; Suwala AK; Raabe EH; Siebzehnrubl FA; Suarez MJ; Orr BA; Bar EE; Maciaczyk J; Eberhart CG
    Brain Pathol; 2015 Nov; 25(6):724-32. PubMed ID: 25521330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
    Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
    Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy.
    Xu H; Rahimpour S; Nesvick CL; Zhang X; Ma J; Zhang M; Zhang G; Wang L; Yang C; Hong CS; Germanwala AV; Elder JB; Ray-Chaudhury A; Yao Y; Gilbert MR; Lonser RR; Heiss JD; Brady RO; Mao Y; Qin J; Zhuang Z
    Oncotarget; 2015 May; 6(14):11882-93. PubMed ID: 25957416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
    Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
    Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway.
    Chen W; Kong KK; Xu XK; Chen C; Li H; Wang FY; Peng XF; Zhang Z; Li P; Li JL; Li FC
    Int J Oncol; 2018 Feb; 52(2):485-495. PubMed ID: 29345288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
    Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
    PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
    Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis.
    Zhang S; Wang W; Liu G; Xie S; Li Q; Li Y; Lin Z
    Biomed Pharmacother; 2017 Nov; 95():711-720. PubMed ID: 28886531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A
    Torres Á; Erices JI; Sanchez F; Ehrenfeld P; Turchi L; Virolle T; Uribe D; Niechi I; Spichiger C; Rocha JD; Ramirez M; Salazar-Onfray F; San Martín R; Quezada C
    Cancer Lett; 2019 Apr; 446():112-122. PubMed ID: 30660649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP-dependent protein kinase is essential for hypoxia-mediated epithelial-mesenchymal transition, migration, and invasion in lung cancer cells.
    Shaikh D; Zhou Q; Chen T; Ibe JC; Raj JU; Zhou G
    Cell Signal; 2012 Dec; 24(12):2396-406. PubMed ID: 22954688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
    Chandra A; Jahangiri A; Chen W; Nguyen AT; Yagnik G; Pereira MP; Jain S; Garcia JH; Shah SS; Wadhwa H; Joshi RS; Weiss J; Wolf KJ; Lin JG; Müller S; Rick JW; Diaz AA; Gilbert LA; Kumar S; Aghi MK
    Cancer Res; 2020 Apr; 80(7):1498-1511. PubMed ID: 32041837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
    Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
    Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.
    Irshad K; Mohapatra SK; Srivastava C; Garg H; Mishra S; Dikshit B; Sarkar C; Gupta D; Chandra PS; Chattopadhyay P; Sinha S; Chosdol K
    PLoS One; 2015; 10(3):e0118201. PubMed ID: 25734817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition.
    Kahlert UD; Maciaczyk D; Doostkam S; Orr BA; Simons B; Bogiel T; Reithmeier T; Prinz M; Schubert J; Niedermann G; Brabletz T; Eberhart CG; Nikkhah G; Maciaczyk J
    Cancer Lett; 2012 Dec; 325(1):42-53. PubMed ID: 22652173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.
    Ren J; Chen Y; Song H; Chen L; Wang R
    J Cell Biochem; 2013 Jun; 114(6):1395-403. PubMed ID: 23255418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.